Interview
Ben Goldacre

Ben Goldacre: Pharma industry has destroyed its own reputation

News
Pills

EU Ombudsman: Clinical trials face new transparency challenges

News
31 drugs intended to treat cancer were approved by the European Medicines Agency (EMA) over the past three years. 2011 [Interpharma/Flickr]

Cancer research at a crossroads in Germany

News
Pills

Growing concerns over medicines agency's proposed rules for transparency

News
Pills

EU Ombudsman worried over lack of transparency at medicines agency

News

EU rules ‘mean children can't get life-saving cancer drugs’

News

EU Parliament, ministers agree to more clinical trial transparency in clinical trials

News

Ending drug trial secrecy is a boon for R&D, says EU agency

News

Health experts critical of pharma industry's new transparency rules

News

Pharma industry downplays lobbyism with patient groups

News

Pharma industry tries to mobilise patient groups in clinical trials battle

News

MEPs give resounding ‘yes’ to new clinical trial rules

News

Court orders EU medicines agency to withhold clinical trial results

News

Health NGO pushes for more transparency in clinical trials

News

Clinical trials debate shifts from research to transparency ahead of EU vote

Opinion

Clinical trials directive: The Parliament's political dilemna

News

US pharma firm seeks to stop EU agency releasing drug data

News

Health experts urge greater gender balance in clinical trials

Interview

Medical director: Women under-represented in clinical tests

News

OECD urges harmonisation of clinical trials to save lives

Interview

MEP: New clinical trial rules will boost EU pharma research

News

Brussels seeks to simplify rules on clinical trials

News

Sufferers want EU ethics code for drug testing

News

EU to revamp Clinical Trials Directive

Page

Advertising
Advertising

Follow us: